Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 15, 2021 - Issue 5
Submit an article Journal homepage
508
Views
2
CrossRef citations to date
0
Altmetric
DRUG PROFILE

Selexipag for the treatment of pulmonary arterial hypertension

Léon Genecandb Pulmonary Hypertension Program, Geneva University Hospitals, Geneva, Switzerland;a Internal Medicine Department,Riviera Chablais Hospital, Rennaz, SwitzerlandCorrespondence[email protected]
View further author information
,
Julie Wackerc Paediatric Cardiology Unit, University Hospitals of Geneva, Switzerland; Centre Universitaire Romand De Cardiologie Et Chirurgie Cardiaque Pédiatrique, University of Geneva and Lausanne, Switzerland;b Pulmonary Hypertension Program, Geneva University Hospitals, Geneva, SwitzerlandView further author information
,
Maurice Beghettic Paediatric Cardiology Unit, University Hospitals of Geneva, Switzerland; Centre Universitaire Romand De Cardiologie Et Chirurgie Cardiaque Pédiatrique, University of Geneva and Lausanne, Switzerland;b Pulmonary Hypertension Program, Geneva University Hospitals, Geneva, SwitzerlandView further author information
&
Frédéric Ladord Department of Medicine Specialties, Division of Pulmonary Diseases, Geneva University Hospitals, Geneva, Switzerland;b Pulmonary Hypertension Program, Geneva University Hospitals, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-4276-635XView further author information
ORCID Icon
Pages 583-595 | Received 30 Sep 2020, Accepted 17 Dec 2020, Published online: 31 Dec 2020

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shun-bin Luo, Er-min Gu, Yu-ao Chen, Shi-chen Zhou, Chen Fan & Ren-ai Xu. (2022) Effect of quercetin on the pharmacokinetics of selexipag and its active metabolite in beagles. Pharmaceutical Biology 60:1, pages 1-8.
Read now

Articles from other publishers (1)

Guofeng Ma, Dan Wang, Xiaoling Xu, Li Liang & Li Xu. (2022) Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma. Medicine 101:28, pages e29412.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.